Founder And CEO
Co-Founding Partner and COO
Chief Financial Officer
Chief People Officer
Chief Growth Officer
General Manager, Sr. Partner
Partner, Launch Excellence Practice Lead
Partner
Partner, Patient Services Practice Lead
Principal, Medical Communications
Principal, Science and Strategy
Principal, Science and Strategy
Partner
Principal
Partner
Principal, Market Access
Principal, Market Access
Vice President, Commercialization
Principal, Launch Excellence
Principal
Principal
Vice President, Business Development
Director, Business Development & Client Success
In her role as Principal, Medical Communications, she helps to support her clients in the development of compelling and strategic stories through various medical communications projects. Spanning a variety of therapeutic areas, these activities support the education, training and engagement needs of cross-functional teams at Canadian and US pharmaceutical companies.
Prior to joining, Kwamaa trained microbiologist, and supported exciting research in molecular microbiology and infectious disease. She holds a MSc in Molecular Genetics from the University of Toronto,
As a lover of live music and with a growing green thumb, Kwamaa can be found at various music events or tending to her growing plant collection.
Learn how we guided our client through early-stage clinical trials and competitive pressures to craft a compelling scientific narrative. Read the case study.
We helped a clinical-stage genetic medicine company enhance their manuscript and figures to meet the high standards of a top scientific journal. Discover how our targeted narrative refinement and figure enhancement led to their research being featured in a prestigious journal with an impact factor of 4.6.
Our biotech client was facing the challenge of introducing a new competitor into the market while simultaneously gaining a deeper understanding of their disease state. To navigate this complex scenario, they needed a strategic document that would serve as the foundation for both internal and external communications.
Our client, a leading biopharmaceutical company, sought to embark on a clinical development program within a new therapeutic area in the rare disease space. Read the case study.
A recent pivotal Phase 3 clinical trial marked a significant milestone for our client, a biopharmaceutical company, in their quest to introduce a novel treatment for major depressive disorder (MDD). Read more.
Careers page, Principal profile
"*" indicates required fields
Careers page Analyst profile
Careers page Manager profile